Most Recent
The ACCC has outlined its enforcement priorities for the year, promising to crack down on misleading pricing by supermarkets, manipulative practices by digital companies and car companies that don't comply with consumer guarantees.
The former manager of biscuits and cookies at Coles has faced cross-examination by the ACCC over marking Arnott’s Shapes with a 'Down Down' discount, despite the price being 50 cents less four weeks prior.
Two units of Queensland real estate firm Coronis have lost a fight with the tax office over service fee deductions claimed for payments to related entities for the use of the Coronis trade mark, among other trust assets.
The Fair Work Commission has found a recruitment agency employee who was sacked after starting a coaching business as a side hustle was not unfairly dismissed.
Facing claims it misled customers with its 'Down Down' pricing, Coles has urged the court not to second guess its judgment, but a judge overseeing the case has said competitive pressures do not excuse misleading promotions.
A judge has ordered Mobil Oil to pay an agreed penalty of $16 million for running ads in far north Queensland over a period of four years falsely claiming that it was supplying a specific brand of fuel with added benefits.
Coles changed its marketing policies after being concerned it could not compete with Woolworths, a court has heard on the first day of trial in the consumer regulator’s case over the supermarket's “utterly misleading” discounts.
Ahead of a first case management hearing this month, superannuation fund trustee Equity Trustees has hit back at ASIC’s action over member's investment in the now defunct Shield fund, saying the regulator failed to warn it.
A former director of two marketing companies linked to the failed Shield and First Guardian funds can leave Australia for 12 days, despite ASIC’s concerns he is a flight risk.
Private hospital operator Ramsay Health has won swift ACCC approval for its $251 million acquisition of Canberra hospital National Capital Private Hospital from Healthscope, with the regulator completing its review in three weeks.